elapsed_time: 18s
was_input_captured: True
original_text: |
    Concurrently using other anticancer therapy. Participants must continue palbociclib and AI or fulvestrant for Phase 1b and palbociclib or ribociclib and AI or fulvestrant for Phase 2.
inclusion: False
